A2Z-31161-43985
3 vaccinations
2 coded responses
25 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 787 / TX
- Registered
- 2020-12-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-20
Dose 1 — Pfizer-BioNTech
-
2020-12-22
Registered in v-safe
- 2020-12-22
- 2020-12-23
- 2020-12-24
- 2020-12-25
- 2020-12-26
- 2020-12-27
- 2021-01-03
-
2021-01-09
Dose 2 — Pfizer-BioNTech
- 2021-01-20
- 2021-01-23
- 2021-01-30
- 2021-02-06
- 2021-02-13
- 2021-02-20
- 2021-04-10
- 2021-07-10
-
2021-09-24
Dose 3 — Pfizer-BioNTech
- 2021-09-29
- 2021-10-01
- 2021-10-08
- 2021-10-15
- 2021-10-22
-
2021-10-29
Survey response — day 35, dose 3MedDRA: Fatigue, Lymphadenopathy, Nasal congestion, SARS-CoV-2 test negative, Secretion discharge, Sinus disorder, Sputum discoloured — Feeling: Poor · Be unable to work or attend schoolFree text: Sinus symptoms with yellow mucus, nasal congestion, swollen lymph nodes, fatigue. No fever, negative Covid testMedDRA releases: 2024-11 · check-in free text available
- 2021-11-05
- 2021-12-24
- 2022-03-25
-
2022-09-25
Survey response — 12 months, dose 3MedDRA: Upper respiratory tract infection — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Upper respiratory infectionnMedDRA releases: 2024-11 · check-in free text available
-
2022-09-25
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-09-26
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-20 | Pfizer-BioNTech | |
| 2 | 2021-01-09 | Pfizer-BioNTech | |
| 3 | 2021-09-24 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 10 — day 35, dose 3
Symptoms: Sinus symptoms with yellow mucus, nasal congestion, swollen lymph nodes, fatigue. No fever, negative Covid test
Release 12 — 12 months, dose 3
Symptoms: Upper respiratory infectionn
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | · | · | ✓ |
| SD | Lymphadenopathy | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Secretion discharge | · | · | ✓ |
| SD | Sinus disorder | · | · | ✓ |
| SD | Sputum discoloured | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release